Sigilon Therapeutics, Inc. EPS - Earnings per Share 2021-2023 | SGTX
Sigilon Therapeutics, Inc. eps - earnings per share from 2021 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Sigilon Therapeutics, Inc. Annual EPS |
| 2022 |
$-17.43 |
| 2021 |
$-31.60 |
| 2020 |
$-98.18 |
| 2019 |
$-139.66 |
| Sigilon Therapeutics, Inc. Quarterly EPS |
| 2023-06-30 |
$-3.00 |
| 2023-03-31 |
$-2.99 |
| 2022-12-31 |
$-2.56 |
| 2022-09-30 |
$-3.51 |
| 2022-06-30 |
$-5.76 |
| 2022-03-31 |
$-5.59 |
| 2021-12-31 |
$-7.15 |
| 2021-09-30 |
$-8.19 |
| 2021-06-30 |
$-8.45 |
| 2021-03-31 |
$-7.80 |
| 2020-12-31 |
$0.13 |
| 2020-09-30 |
$-32.12 |
| 2020-06-30 |
$-33.03 |
| 2020-03-31 |
$-33.16 |
